U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  1. About Science & Research at FDA

FDA Grand Rounds

FDA Grand Rounds

The FDA Grand Rounds is an educational presentation that is webcast monthly to highlight cutting-edge research underway across the Agency and its impact on protecting and advancing public health. Each session features an FDA scientist presenting on a key public health challenge and how FDA is applying science to its regulatory activities. The 45-minute educational presentation is followed by questions from the audience. You can also view the presentation under Past Grand Rounds following the live webcast. #FDAGrandRounds.

Upcoming Event

FDA Grand Rounds: Evaluating Mutagenicity by Error-corrected Sequencing

Thursday, March 14, 2024
12:00 p.m. - 1:00 p.m. ET
Webcast

About the Speaker

Javier Revollo, Ph.D.
Research Biologist
Division of Genetic and Molecular Toxicology
National Center for Toxicological Research (NCTR)
U.S. Food and Drug Administration (FDA) 

Dr. Revollo is a Research Biologist and Principal Investigator in the Division of Genetic and Molecular Toxicology at the National Center for Toxicological Research. He studied at the University of Wisconsin-Madison (B.S. in Genetics, 1997-2000), Washington University in St. Louis (Ph.D. in Molecular Cell Biology, 2001-2006), and pursued postdoctoral studies at the National Institutes of Health (NIH) (2007-2012). Javier joined the FDA due to his expertise in genomics, DNA sequencing, and bioinformatics. His research efforts at the FDA have focused on the development of DNA sequencing methods and bioinformatic algorithms to study somatic mutations.

Past Grand Rounds

2024

2023

2022

2021

2020

2019

2018

2017

2016

Resources For You


Sub-Topic Paragraphs

Latest From the Commissioner

Remarks by Commissioner Robert M. Califf to the 2023 Global Summit on Regulatory Science - 09/26/2023

Oct 02

Examining Medical Product Development in the Wake of the Ebola Epidemic -

Mar 29

Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development - 06/14/2017

Feb 16

Researching the Potential Medical Benefits and Risks of Marijuana - 07/12/2016

Feb 20

Reviewing the Rising Price of EpiPens - 09/21/2016

Feb 16

Exploring a Right to Try for Terminally Ill Patients - 09/22/2016

Sep 22

Prioritizing Public Health: The FDA’s Role in the Generic Drug Marketplace - 09/26/2016

Feb 16

Waste and Duplication in the USDA Catfish Inspection Program - 12/07/2016

Feb 20


Back to Top